KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Change in Account Payables: 2010-2025

Historic Change in Account Payables for Incyte (INCY) over the last 16 years, with Sep 2025 value amounting to -$44.2 million.

  • Incyte's Change in Account Payables fell 244.64% to -$44.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.4 million, marking a year-over-year decrease of 118.74%. This contributed to the annual value of $88.2 million for FY2024, which is 152.49% up from last year.
  • Per Incyte's latest filing, its Change in Account Payables stood at -$44.2 million for Q3 2025, which was down 321.82% from $19.9 million recorded in Q2 2025.
  • Over the past 5 years, Incyte's Change in Account Payables peaked at $114.4 million during Q4 2022, and registered a low of -$221.9 million during Q1 2023.
  • Moreover, its 3-year median value for Change in Account Payables was -$2.2 million (2025), whereas its average is -$9.7 million.
  • Its Change in Account Payables has fluctuated over the past 5 years, first skyrocketed by 342.58% in 2021, then plummeted by 1,034.35% in 2023.
  • Quarterly analysis of 5 years shows Incyte's Change in Account Payables stood at $57.6 million in 2021, then spiked by 98.56% to $114.4 million in 2022, then plummeted by 126.06% to -$29.8 million in 2023, then spiked by 163.90% to $19.1 million in 2024, then slumped by 244.64% to -$44.2 million in 2025.
  • Its Change in Account Payables stands at -$44.2 million for Q3 2025, versus $19.9 million for Q2 2025 and -$2.2 million for Q1 2025.